AAAAAA
Results:
1-15
|
Results: 15
Authors:
BABB J
ROGATKO A
ZACKS S
Citation: J. Babb et al., CANCER PHASE-I CLINICAL-TRIALS - EFFICIENT DOSE-ESCALATION WITH OVERDOSE CONTROL, Statistics in medicine, 17(10), 1998, pp. 1103-1120
Authors:
MONTGOMERY RC
HOFFMAN JP
RILEY LB
ROGATKO A
RIDGE JA
EISENBERG BL
Citation: Rc. Montgomery et al., PREDICTION OF RECURRENCE AND SURVIVAL BY POSTRESECTION CA-19-9 VALUESIN PATIENTS WITH ADENOCARCINOMA OF THE PANCREAS, Annals of surgical oncology, 4(7), 1997, pp. 551-556
Authors:
REBBECK TR
JORDAN HA
SCHNUR RE
ROGATKO A
Citation: Tr. Rebbeck et al., UTILITY OF LINKED MARKERS IN GENETIC-COUNSELING - ESTIMATION OF CARRIER RISKS IN X-LINKED OCULAR ALBINISM, American journal of medical genetics, 70(1), 1997, pp. 58-66
Authors:
SCHILDER RJ
MILLENSON MM
ENTMACHER M
ROGATKO A
YESLOW G
HALBHERR T
PADAVICSHALLER K
YOUNG RC
SMITH MR
Citation: Rj. Schilder et al., PHASE-II TRIAL OF DEXAMETHASONE (DEX) AND 13-CIS-RETINOIC ACID (CRA) AS FIRST-LINE TREATMENT FOR MULTIPLE-MYELOMA, Blood, 90(10), 1997, pp. 4141-4141
Authors:
SMITH MR
BOYD RL
MINNITTI C
CLYDE J
HOESSLY MC
CORNFELD M
YESLOW G
HALBHERR T
ROGATKO A
SCHILDER RJ
YOUNG RC
MILLENSON MM
Citation: Mr. Smith et al., PHASE-II TRIAL OF FLUDARABINE ALTERNATING WITH INTERFERON (IFN)ALPHA-2B IN LOW-GRADE NON-HODGKINS-LYMPHOMA (NHL), Blood, 90(10), 1997, pp. 861-861
Authors:
ROGATKO A
LITWIN S
Citation: A. Rogatko et S. Litwin, PHASE-II STUDIES - WHICH IS WORSE, FALSE-POSITIVE OR FALSE-NEGATIVE, Journal of the National Cancer Institute, 88(7), 1996, pp. 462-462
Authors:
OBASAJU CK
JOHNSON SW
ROGATKO A
KILPATRICK D
BRENNAN JM
HAMILTON TC
OZOLS RF
ODWYER PJ
GALLO JM
Citation: Ck. Obasaju et al., EVALUATION OF CARBOPLATIN PHARMACOKINETICS IN THE ABSENCE AND PRESENCE OF PACLITAXEL, Clinical cancer research, 2(3), 1996, pp. 549-552
Authors:
HAGEBOUTROS A
ROGATKO A
NEWMAN EM
MCALEER C
BRENNAN J
LACRETA FP
HUDES GR
OZOLS RF
ODWYER PJ
Citation: A. Hageboutros et al., PHASE-I STUDY OF PHOSPHONACETYL-L-ASPARTATE, 5-FLUOROURACIL, AND LEUCOVORIN IN PATIENTS WITH ADVANCED CANCER, Cancer chemotherapy and pharmacology, 35(3), 1995, pp. 205-212
Authors:
ROGATKO A
Citation: A. Rogatko, RISK PREDICTION WITH LINKED MARKERS - THEORY, American journal of medical genetics, 59(1), 1995, pp. 14-23
Authors:
ROGATKO A
REBBECK T
ZACKS S
Citation: A. Rogatko et al., RISK PREDICTION WITH LINKED MARKERS - PEDIGREE ANALYSIS, American journal of medical genetics, 59(1), 1995, pp. 24-32
Authors:
GWIN JL
KLEINSZANTO AJP
ZHANG SY
AGARWAL P
ROGATKO A
KELLER SM
Citation: Jl. Gwin et al., LOSS OF BLOOD-GROUP ANTIGEN-A IN NONSMALL CELL LUNG-CANCER, Annals of surgical oncology, 1(5), 1994, pp. 423-427
Authors:
SCHILDER RJ
LACRETA FP
PEREZ RP
JOHNSON SW
BRENNAN JM
ROGATKO A
NASH S
MCALEER C
HAMILTON TC
ROBY D
YOUNG RC
OZOLS RF
ODWYER PJ
Citation: Rj. Schilder et al., PHASE-I AND PHARMACOKINETIC STUDY OF ORMAPLATIN (TETRAPLATIN, NSC-363812) ADMINISTERED ON A DAY-1 AND DAY-8 SCHEDULE, Cancer research, 54(3), 1994, pp. 709-717
Authors:
PIGNATELLI B
MALAVEILLE C
ROGATKO A
HAUTEFEUILLE A
THUILLIER P
MUNOZ N
MOULINIER B
BERGER F
DEMONTCLOS H
LAMBERT R
CORREA P
RUIZ B
SOBALA GM
SCHORAH CJ
AXON ATR
BARTSCH H
Citation: B. Pignatelli et al., MUTAGENS, N-NITROSO COMPOUNDS AND THEIR PRECURSORS IN GASTRIC-JUICE FROM PATIENTS WITH AND WITHOUT PRECANCEROUS LESIONS OF THE STOMACH, European journal of cancer, 29A(14), 1993, pp. 2031-2039
Authors:
ROGATKO A
REBBECK TR
Citation: A. Rogatko et Tr. Rebbeck, ESTIMATION AND PRECISION OF GENETIC RISK TO DISEASE USING MULTIPLE LINKED MARKERS, American journal of human genetics, 53(3), 1993, pp. 851-851
Authors:
ROGATKO A
ZACKS S
Citation: A. Rogatko et S. Zacks, ORDERING GENES - CONTROLLING THE DECISION-ERROR PROBABILITIES, American journal of human genetics, 52(5), 1993, pp. 947-957
Risultati:
1-15
|